# US 2018/0021084 A1 · Radio-frequency electrical membrane breakdown for reducing restenosis > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2018/0021084 A1 - Document ID: US20180021084A1 - Status: Published application - Kind: A1 - Application number: 15/548,935 - Filed: 2016-02-04 - Published: 2018-01-25 - Earliest claimed: 2015-02-04 - Applicants: RFEMB Holdings, LLC - Inventors: Gary M. Onik; James A. Miessau; David G. Bostwick - Web page: https://patentgrep.com/patent/US20180021084A1 ## CPC - A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)} - A61B 18/1815: {using microwaves} - A61B 18/1206: {Generators therefor} - A61B 34/20: Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis - A61B 2017/00172: {Pulse trains, bursts, intermittent continuous operation} - A61B 2017/00703: {correcting for movement of heart, e.g. ECG-triggered} - A61B 2018/0022: {Balloons} - A61B 2018/00422: {Angioplasty} - A61B 2018/00547: {Prostate} - A61B 2018/00642: {with feedback, i.e. closed loop control} - A61B 2018/00702: {Power or energy} - A61B 2018/00714: {Temperature} - A61B 2018/00779: {Power or energy} - A61B 2018/00821: {measured by a thermocouple} - A61B 2018/00839: {Bioelectrical parameters, e.g. ECG, EEG} - A61B 2018/1253: {monopolar} - A61B 2018/126: {bipolar} - A61B 2034/2051: {Electromagnetic tracking systems} - A61B 2090/365: {augmented reality, i.e. correlating a live optical image with another image} - A61B 2090/374: {NMR or MRI} - A61B 2090/376: {using X-rays, e.g. fluoroscopy} - A61B 2090/3762: {using computed tomography systems [CT]} - A61B 2090/378: {using ultrasound} - A61F 2/958: Inflatable balloons for placing stents or stent-grafts - A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D) - A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C) ## Abstract An Imaging, guidance, planning and treatment system integrated into a single unit or assembly of components, and a method for using same, that can be safely and effectively deployed to treat re-stenosis from m intra vascular location in various medical settings, including in a hospital or in an outpatient setting. The system utilizes the novel process of Radio-Frequency Electrical Membrane Breakdown (“EMB” or “RFEMB”) to destroy the cellular membranes of unwanted tissue without denaturing the intracellular contents of the cells comprising the tissue, thus preventing or alleviating re-stenosis after an angioplasty-type procedure. The system preferably comprises at least one EMB treatment catheter-type probe 20, at least one temperature sensor 7, and at least one controller unit for at least partially automating the treatment process. ## Claims ### Claim 1 A method of treating restenosis in a living subject using radio frequency electrical membrane breakdown, the method comprising: identifying a location of a vascular blockage in a blood vessel within said living subject; introducing a catheter-type treatment probe to said location, said catheter-type treatment probe comprising at least one electrode; removing said vascular blockage from within said blood vessel of said living subject; and applying to an interior surface of said blood vessel at said location, via said at least one electrode, an electric field sufficient to cause electrical membrane breakdown of a cell membrane of a plurality of cells of said soft tissue to cause immediate spillage of all intracellular components into an extracellular space and exposure of an internal constituent part of said cell membrane to said extracellular space. ### Claim 2 (depends on 1) The method of claim 1, wherein said step of removing said vascular blockage occurs prior to said step of applying said electric field. ### Claim 3 (depends on 1) The method of claim 1, wherein said step of removing said vascular blockage occurs after said step of applying said electric field. ### Claim 4 (depends on 1) The method of claim 1, wherein said step of removing said vascular blockage occurs at substantially the same time as said step of applying said electric field. ### Claim 5 (depends on 1) The method of claim 1, wherein said method is performed without administering general anesthesia or a neuromuscular blockade to said living subject. ### Claim 6 (depends on 1) The method of claim 1, wherein said step of removing said vascular blockage comprises placing a stent at said location of said blood vessel. ### Claim 7 (depends on 6) The method of claim 6, wherein said step of placing a stent comprises placing a non-pharmacological stent at said location of said blood vessel. ### Claim 8 (depends on 1) The method of claim 1, wherein said method is performed at least in part by a robotic arm. ### Claim 9 (depends on 1) The method of claim 1, wherein said step of introducing said catheter-type treatment probe to said location comprises: performing a scan of at least a portion of said living subject; generating an electronic 3D Fused Image using data obtained from said step of performing a scan; overlaying at least one virtual catheter-type treatment probe over said 3D Fused Image in one or more configurations; determining a treatment effect for each of said one or more configurations; determining an optimal placement location of said catheter-type treatment probe based on said treatment effects of said one or more configurations; and introducing said catheter-type treatment probe into said living subject at said optimal placement location. ### Claim 10 (depends on 9) The method of claim 9, wherein said step of performing a scan comprises performing a CT scan of said living subject. ### Claim 11 (depends on 9) The method of claim 9, wherein said step of generating an electronic 3D Fused Image comprises overlaying the results of a two-dimensional scan of said living subject with the results of a contrast CT scan of said living subject. ### Claim 12 (depends on 1) The method of claim 1, wherein said step of removing said vascular blockage comprises placing a stent in said location of said vascular blockage. ### Claim 13 (depends on 12) The method of claim 12, wherein said stent is metal. ### Claim 14 (depends on 1) The method of claim 1, wherein said step of removing said vascular blockage comprises performing by-pass surgery at said location of said vascular blockage. ### Claim 15 (depends on 1) The method of claim 1, wherein said step of removing said vascular blockage comprises performing a balloon angioplasty at said location of said vascular blockage. ### Claim 16 A system for treating restenosis in a living subject using radio frequency electrical membrane breakdown, the system comprising: an electric pulse generator; at least one therapeutic catheter-type probe comprising at least one electrode operatively connected to said pulse generator, said probe and pulse generator configured to apply to said endothelial cells and intravascular tissue an electric field sufficient to cause electrical membrane breakdown of a cell membrane of a plurality of cells of said soft tissue to cause immediate ablation thereof; and a controller operatively connected to said electric pulse generator and said therapeutic catheter-type probe. ### Claim 17 (depends on 16) The system of claim 16, said system further comprising at least one thermocouple operatively connected to said controller. ### Claim 18 (depends on 16) The system of claim 16, the system further comprising at least two electrodes, and wherein said at least two electrodes are located at a pre-determined distance from one another on an outer surface of said at least one therapeutic catheter-type probe. ### Claim 19 (depends on 16) The system of claim 16, wherein a first one of said at least one electrodes forms a core of said at least one catheter-type probes, and wherein said at least one catheter-type probe further comprises an insulating sheath comprised of a non-electrically-conductive material surrounding said core on at least one side, wherein a second one of said at least one electrodes is disposed on an outer surface of said insulating sheath. ### Claim 20 (depends on 16) The system of claim 16, wherein said at least one catheter-type probe is a balloon catheter comprising an expandable balloon. ### Claim 21 (depends on 20) The system of claim 20, wherein said at least one catheter-type probe comprises a means for stent delivery. ### Claim 22 (depends on 21) The system of claim 21, wherein said at least one electrode is located on an outer surface of a stent located on said at least one catheter-type probe. ### Claim 23 (depends on 20) The system of claim 20, wherein said at least one electrode is placed on an outer surface of said expandable balloon. ### Claim 24 (depends on 16) The system of claim 16, wherein said at least one catheter-type probe further comprises a central lumen sized to enable injection of materials into said living subject. ### Claim 25 (depends on 16) The system of claim 16, wherein said at least one catheter-type probe further comprises a central lumen sized to enable removal of materials from said living subject.